Xu Y - Search Results

1

Design, synthesis and biological activity of 4-(4-benzyloxy)phenoxypiperidines as selective and reversible LSD1 inhibitors.

Xi J, Xu S, Zhang L, Bi X, Ren Y, Liu YC, Gu Y, Xu Y, Lan F, Zha X. Xi J, et al. Among authors: xu s, xu y. Bioorg Chem. 2018 Aug;78:7-16. doi: 10.1016/j.bioorg.2018.02.016. Epub 2018 Feb 16. Bioorg Chem. 2018. PMID: 29524666

2

Benzimidazol-2-yl or benzimidazol-2-ylthiomethyl benzoylguanidines as novel Na+/H+ exchanger inhibitors, synthesis and protection against ischemic-reperfusion injury.

Zhang R, Lei L, Xu YG, Hua WY, Gong GQ. Zhang R, et al. Bioorg Med Chem Lett. 2007 May 1;17(9):2430-3. doi: 10.1016/j.bmcl.2007.02.035. Epub 2007 Feb 17. Bioorg Med Chem Lett. 2007. PMID: 17346962

3

Design, synthesis and biological evaluation of novel substituted benzoylguanidine derivatives as potent Na+/H+ exchanger inhibitors.

Xu WT, Jin N, Xu J, Xu YG, Wang QJ, You QD. Xu WT, et al. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3283-7. doi: 10.1016/j.bmcl.2009.04.079. Epub 2009 Apr 23. Bioorg Med Chem Lett. 2009. PMID: 19433354

4

Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives.

Zhang R, Dong J, Xu YG, Hua WY, Wen N, You QD. Zhang R, et al. Eur J Med Chem. 2009 Sep;44(9):3771-6. doi: 10.1016/j.ejmech.2009.04.036. Epub 2009 May 5. Eur J Med Chem. 2009. PMID: 19482383

5

Synthesis and Na(+)/H(+) exchanger-1 inhibitory activity of substituted (quinolinecarbonyl)guanidine derivatives.

Mao D, Xu Y, Hu X, Zhang G, Dong J, Gong G. Mao D, et al. Among authors: xu y. Chem Biodivers. 2009 Oct;6(10):1727-36. doi: 10.1002/cbdv.200800268. Chem Biodivers. 2009. PMID: 19842138

6

Synthesis of novel ligustrazine derivatives as NA+/H+ exchange inhibitors.

Ren M, Dong J, Xu Y, Wen N, Gong G. Ren M, et al. Among authors: xu y. Chem Biodivers. 2010 Nov;7(11):2727-36. doi: 10.1002/cbdv.200900353. Chem Biodivers. 2010. PMID: 21072772

7

Synthesis and Na+/H+ exchanger inhibitory activity of benzoylguanidine derivatives.

Jin L, Jiang XM, Du P, Xu J, Gong GQ, Wang QJ, Xu YG. Jin L, et al. Eur J Med Chem. 2011 Sep;46(9):4107-16. doi: 10.1016/j.ejmech.2011.06.011. Epub 2011 Jun 17. Eur J Med Chem. 2011. PMID: 21724305

8

Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity.

Yang XZ, Yang WH, Xu YG, Diao XJ, He GW, Gong GQ. Yang XZ, et al. Eur J Med Chem. 2012 Nov;57:21-8. doi: 10.1016/j.ejmech.2012.09.016. Epub 2012 Sep 18. Eur J Med Chem. 2012. PMID: 23043765

9

Design, synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing methyl ferulate.

Yang XZ, Diao XJ, Yang WH, Li F, He GW, Gong GQ, Xu YG. Yang XZ, et al. Bioorg Med Chem Lett. 2013 Apr 1;23(7):2089-92. doi: 10.1016/j.bmcl.2013.01.126. Epub 2013 Feb 8. Bioorg Med Chem Lett. 2013. PMID: 23466230

10

Design, synthesis and biological evaluation of novel imidazo[4,5-c]pyridinecarboxamide derivatives as PARP-1 inhibitors.

Zhu Q, Wang X, Chu Z, He G, Dong G, Xu Y. Zhu Q, et al. Among authors: xu y. Bioorg Med Chem Lett. 2013 Apr 1;23(7):1993-6. doi: 10.1016/j.bmcl.2013.02.032. Epub 2013 Feb 16. Bioorg Med Chem Lett. 2013. PMID: 23481647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,243 results

Search Page

Filters